Alzheimer's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
For people with Alzheimer's dementia:
- Adults aged over 60 years old who have been diagnosed with Alzheimer's dementia
- People who score less than 24 on a memory and thinking test called the Korean Mini-Mental State Examination (K-MMSE)
- People who score 0.5 or higher on a scale used to measure dementia severity, called the Clinical Dementia Rating (CDR)
For healthy participants:
- Adults aged over 60 years old who do not have dementia
- People who score 24 or above on the Korean Mini-Mental State Examination (K-MMSE)
- People who score 0 on the Clinical Dementia Rating (CDR), meaning no signs of dementia
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have serious or unstable health conditions affecting the heart, digestive system, breathing, hormones, or other body systems, and who are generally in poor health
- People whose memory and thinking difficulties are severe enough that they cannot consent for themselves (scoring below 10 on the MMSE), unless a legal guardian or carer is present to accompany them
- People whom the research team decides, for any other reason, are not suitable to participate in this trial
Note: People who are currently in another study, or who have taken part in another study within the past 30 days, may still be considered eligible for this trial (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: MinYoung Kim, MD, PhD, CHA Bundang Medical Center
Phone: 82-31-780-6281
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
genetic analysis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.